Tongtong Xue

机构：Beijing Institute of Technology, Shanxi Medical University, Suzhou Research Institute, Advanced Research Institute, Shanxi Academy of Medical Sciences, Ministry of Industry and Information Technology

发表论文 30 篇 · 总被引 526 次 · h-index 10

代表论文

• COVID19: an announced pandemic (2020 · Cell Death and Disease · 被引 125)
• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 93)
• Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic‐activated CXCL5‐CXCR2‐Erk signaling cascades (2021 · International Journal of Cancer · 被引 68)
• A first in-human study of A166 in patients with locally advanced/metastatic solid tumors which are HER2-positive or HER2-amplified who did not respond or stopped responding to approved therapies. (2020 · Journal of Clinical Oncology · 被引 50)
• Identifying unsafe behaviors of construction workers through an unsupervised multi-anomaly GAN approach (2024 · Automation in Construction · 被引 21)
• SKB264 ADC: A first-in-human study of SKB264 in patients with locally advanced unresectable/metastatic solid tumors who are refractory to available standard therapies. (2020 · Journal of Clinical Oncology · 被引 21)